<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20261001071250N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-10-05</date_registration>
      <primary_sponsor>University of Tehran</primary_sponsor>
      <public_title>Development and evaluation of a protocol based on the experiences of adolescents who have attempted suicide.</public_title>
      <acronym></acronym>
      <scientific_title>Development and Preliminary Evaluation of a Lived-Experience-Informed Protocol for Reducing the Severity of Suicidal Ideation in Adolescents</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-06-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/93760</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Other, Purpose: Health service research, Other design features: Randomized controlled trial, Randomization description: Randomized Controlled
After identifying eligible individuals, each participant was assigned a unique code. Then, using a table of random numbers, the individuals were evenly assigned to two groups—an experimental group (15 participants) and a control group (15 participants)—to ensure the groups were as homogeneous as possible regarding background variables such as age, gender, and the severity of suicidal thoughts, Blinding description: The participants were unaware of the existence of two groups, and the two groups were completely separate.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Suicidal thoughts or suicide attempts.</hc_freetext>
      <i_freetext>Intervention group: Adolescents with suicidal thoughts in the intervention group received training (based on a prevention protocol developed by the researcher), and the changes were examined..</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is I have not yet obtained the professor's permission.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>فاطمه شاکری</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Dr. Beheshti Street, Shahid Moradi Alley, Behvarz Training Center (next to the Central Laboratory)</address>
        <city>Abhar</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4561917769</zip>
        <telephone>+98 24 3527 8230</telephone>
        <email>shakeri.fatemeh@ut.ac.ir</email>
        <affiliation>University of Zanjan</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hadi Bahrami Ehsan</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Chamran Highway, Jalal-e-Al-Ahmad Street, opposite Kuye Nasr, Dr. Kardan Street</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1445983861</zip>
        <telephone>00982188234162-9</telephone>
        <email>hbahrami@ut.ac.ir</email>
        <affiliation>Faculty of Psychology, University of Tehran</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Aged between 12 and 18 years
Current or past experience of suicidal thoughts or actions
Cognitive and communication abilities suitable for an interview
Ability to articulate experiences and feelings related to the topic
Consent from the adolescent and their parent or guardian to participate in the research</inclusion_criteria>
      <agemin>12 years</agemin>
      <agemax>18 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Unwillingness to continue participation at any stage
Excessive absence from intervention sessions
Concurrent receipt of similar psychological intervention during the course of the research
Occurrence of circumstances rendering the individual's continued participation unsuitable</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Adolescents with suicidal thoughts in the intervention group received training (based on a prevention protocol developed by the researcher), and the changes were examined.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Severity of suicidal ideation, hopelessness, emotion regulation difficulties, and perceived social support. Timepoint: The adjusted mean BSSI score was 12.32 for the experimental group and 23.41 for the control group; thus, after controlling for pre-test scores, an 11.09-point difference was observed between the two groups. Method of measurement: Multivariate analysis of covariance (MANCOVA) was used to select eligible participants—based on scores exceeding the cut-off points on the BSSI, the Beck Scale for Suicide Ideation, the Beck Hopelessness Scale, the Difficulties in Emotion Regulation Scale, and the Multidimensional Scale of Perceived Social Support—and to examine changes following the intervention.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>BHS، DERS، MSPSS. Timepoint: Two months for the qualitative phase, two months for protocol development, and two months for evaluation and implementation. Method of measurement: Severity of suicidal ideation: The Beck Scale for Suicide Ideation (BSSI) consists of 19 core items, each scored on a three-point scale ranging from zero to two. The total score ranges from 0 to 38. The Emotion Regulation Difficulty Scale consists of 36 items and six main components.  The MSPSS scale consists of 12 items and three main sources of social support.؛ To assess the level of hopelessness and negative attitudes toward the future among participants, the 20-item Beck Hopelessness Scale was used, which employs a dichotomous (true/false) response format.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>University of Tehran</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-04-07</approval_date>
        <contact_name>Ethics Committee of the Faculty of Psychology, University of Tehran</contact_name>
        <contact_address>Shahid Chamran Highway, Jalal-e-Al-Ahmad Street, opposite Kuye Nasr, Dr. Kardan Street Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
